Trial intelligence / Profile preview

StemEx in Elderly Umbilical Cord Transplantation

NCT01484470Phase 2Completed

Sponsor
Loyola University Chicago
Start
Jan 2010
Primary completion
Nov 2018
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of carlecortemcel-l in hematologic malignancy, sponsored by Loyola University Chicago. Started Jan 2010; status: completed.

02

Drugs

carlecortemcel-l
03

Conditions

hematologic malignancy

Beyond the preview

Go deeper on NCT01484470.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01484470.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call